Molbio Diagnostics Ltd.

NSE: MOLBIO | BSE: 544866 | ISIN: INE869T01028 | Industry: Healthcare Services
|
1350.8000 36.70 (2.79%)
NSE Nov 03, 2026 15:31 PM
Volume: 596.7K
 

1350.80
2.79%
Motilal Oswal
Molbio is a diagnostics technology company built around Truenat, its portable molecular testing platform that enables rapid point-of-care testing (POCT) with minimal infrastructure — bringing molecular diagnostics closer to the patient.
Molbio Diagnostics has gained 67.39% in the last 3 Months
More from Molbio Diagnostics Ltd.
Recommended